Todd C. Davis, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 18,000 shares at $239.93 ($4.3M) on 2018-08-16, disclosed to the SEC on 2018-08-17.
Open-market sale of $4.3M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $239.93 | 5,833 | $1.4M | 32.4% |
| 2 | $239.93 | 5,833 | $1.4M | 32.4% |
| 3 | $239.50 | 3,167 | $758K | 17.6% |
| 4 | $239.50 | 3,167 | $758K | 17.6% |
| Total | $239.78 avg | 18,000 | $4.3M | 100% |
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |